Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-19-005061
Filing Date
2019-04-30
Accepted
2019-04-30 17:24:13
Documents
4
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A azrx10ka_dec312018.htm 10-K/A 493976
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 18692
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 18864
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 11815
  Complete submission text file 0001654954-19-005061.txt   544441
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K/A | Act: 34 | File No.: 001-37853 | Film No.: 19783338
SIC: 2834 Pharmaceutical Preparations